九典制药：获药物临床试验批准通知书

Core Viewpoint - Jizhen Pharmaceutical has received approval from the National Medical Products Administration for clinical trials of drugs JIZM01 and JIZM02, indicating progress in its research and development efforts [1] Group 1: Company Developments - Jizhen Pharmaceutical announced on September 24 that it has obtained the clinical trial approval for drugs JIZM01 and JIZM02 [1] - JIZM01 is intended for the treatment of closed soft tissue contusions and joint sprains [1] - JIZM02 is aimed at treating periarthritis of the shoulder [1]